New year, new CEOs for Covid vaccine makers CureVac and Novavax
Two biotech companies that have been on long journeys to push through Covid vaccines are getting new CEOs this year.
CureVac CEO Franz-Werner Haas is stepping aside after three years in the position for a new chief who’s coming from Sanofi. Alexander Zehnder will join CureVac as CEO of the mRNA biotech on April 1, leaving his current position as global head of oncology at Sanofi. According to a CureVac representative, “it’s currently not planned” that Haas will remain on the management board after stepping down as CEO.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.